Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
SN18NQvCazVaNNRS
